Boill Healthcare Holdings Limited provided consolidated earnings guidance for the six months ended 30 September 2022. For the period, the Group is expected to record a consolidated net loss of not less than approximately HKD 128 million for the Period, as compared with the consolidated net loss of approximately HKD 27 million for the six months ended 30 September 2021. Such expected substantial consolidated net loss for the Period was mainly due to the following factors: the expected fair value loss on investment properties and impairment loss on property, plant and equipment for the Period due to the adverse impact caused by the outbreak of COVID-19 pandemic and weakened demand of potential home-buying customers due to deterioration of their overall financial condition brought by the uncertain global macro-economic environment; and the decrease in revenue and gross profit recognised during the Period as a result of delay of properties delivery during the COVID-19 lockdown in certain cities in Mainland China.